Stepronin

Identification

Generic Name
Stepronin
DrugBank Accession Number
DB01423
Background

Strepronin is a mucolytic drug. A mucolytic agent is any agent which dissolves thick mucus usually used to help relieve respiratory difficulties. The viscosity of mucous secretions in the lungs is dependent upon the concentrations of mucoprotein as well as the presence of disulfide bonds between these macromolecules and DNA.

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 273.329
Monoisotopic: 273.012949225
Chemical Formula
C10H11NO4S2
Synonyms
  • Stepronin
  • Stepronine
  • Stepronino
  • Steproninum
  • Tiofacic

Pharmacology

Indication

Strepronin is a mucolytic (expectorant) drug.

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

The drug promotes drainage of mucus from the lungs by thinning the mucus and lubricating the irritated respiratory tract

Mechanism of action

An expectorant increases bronchial secretions and mucolytics help loosen thick bronchial secretions. Expectorants reduce the thickness or viscosity of bronchial secretions thus increasing mucus flow that can be removed more easily through coughing, Mucolytics break down the chemical structure of mucus molecules. The mucus becomes thinner and can be removed more easily through coughing.

Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AbataceptThe risk or severity of adverse effects can be increased when Abatacept is combined with Stepronin.
AdalimumabThe risk or severity of adverse effects can be increased when Adalimumab is combined with Stepronin.
Adenovirus type 7 vaccine liveThe risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Stepronin.
AldesleukinThe risk or severity of adverse effects can be increased when Aldesleukin is combined with Stepronin.
AlefaceptThe risk or severity of adverse effects can be increased when Alefacept is combined with Stepronin.
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Product Ingredients
IngredientUNIICASInChI Key
Stepronin sodiumFR96Q1BI9E78126-10-0LAKRODSFPQQVBB-UHFFFAOYSA-M

Categories

ATC Codes
R05CB11 — Stepronin
Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.
Kingdom
Organic compounds
Super Class
Organic acids and derivatives
Class
Carboxylic acids and derivatives
Sub Class
Amino acids, peptides, and analogues
Direct Parent
N-acyl-alpha amino acids
Alternative Parents
Thiophene carboxylic acids and derivatives / Heteroaromatic compounds / Thioesters / Secondary carboxylic acid amides / Carbothioic S-esters / Sulfenyl compounds / Monocarboxylic acids and derivatives / Carboxylic acids / Organopnictogen compounds / Organonitrogen compounds
show 3 more
Substituents
Aromatic heteromonocyclic compound / Carbonyl group / Carbothioic s-ester / Carboxamide group / Carboxylic acid / Heteroaromatic compound / Hydrocarbon derivative / Monocarboxylic acid or derivatives / N-acyl-alpha-amino acid / Organic nitrogen compound
show 13 more
Molecular Framework
Aromatic heteromonocyclic compounds
External Descriptors
Not Available
Affected organisms
  • Humans and other mammals

Chemical Identifiers

UNII
0NOY894QRB
CAS number
72324-18-6
InChI Key
JNYSEDHQJCOWQU-UHFFFAOYSA-N
InChI
InChI=1S/C10H11NO4S2/c1-6(9(14)11-5-8(12)13)17-10(15)7-3-2-4-16-7/h2-4,6H,5H2,1H3,(H,11,14)(H,12,13)
IUPAC Name
2-[2-(thiophene-2-carbonylsulfanyl)propanamido]acetic acid
SMILES
CC(SC(=O)C1=CC=CS1)C(=O)NCC(O)=O

References

General References
Not Available
Human Metabolome Database
HMDB0015492
PubChem Compound
54120
PubChem Substance
46507364
ChemSpider
48889
RxNav
2375829
ChEBI
135129
ChEMBL
CHEMBL2107531
PharmGKB
PA164748630
Wikipedia
Stepronin

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Suppository
Tablet
Granule
Granule, for suspensionOral
Powder, for solution
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.211 mg/mLALOGPS
logP1.29ALOGPS
logP1.27Chemaxon
logS-3.1ALOGPS
pKa (Strongest Acidic)3.56Chemaxon
pKa (Strongest Basic)-4.6Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count4Chemaxon
Hydrogen Donor Count2Chemaxon
Polar Surface Area83.47 Å2Chemaxon
Rotatable Bond Count6Chemaxon
Refractivity64.8 m3·mol-1Chemaxon
Polarizability25.98 Å3Chemaxon
Number of Rings1Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.7834
Blood Brain Barrier+0.8925
Caco-2 permeable-0.6881
P-glycoprotein substrateNon-substrate0.6071
P-glycoprotein inhibitor INon-inhibitor0.9693
P-glycoprotein inhibitor IINon-inhibitor0.9626
Renal organic cation transporterNon-inhibitor0.9546
CYP450 2C9 substrateNon-substrate0.6679
CYP450 2D6 substrateNon-substrate0.8149
CYP450 3A4 substrateNon-substrate0.6934
CYP450 1A2 substrateNon-inhibitor0.8722
CYP450 2C9 inhibitorNon-inhibitor0.8673
CYP450 2D6 inhibitorNon-inhibitor0.9494
CYP450 2C19 inhibitorNon-inhibitor0.8365
CYP450 3A4 inhibitorNon-inhibitor0.905
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9385
Ames testNon AMES toxic0.8822
CarcinogenicityNon-carcinogens0.8835
BiodegradationReady biodegradable0.8478
Rat acute toxicity2.0075 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9968
hERG inhibition (predictor II)Non-inhibitor0.9441
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-03du-9610000000-32727737eab60f2bd665
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-03di-2910000000-1a4171f24b5fbcb1ce97
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-03di-2900000000-96a29b8be986f5490efd
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-001v-9500000000-95609b1409ac265231f3
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-08gi-9600000000-8852447a31eedb7535ac
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-05ai-9000000000-e7a773db2781761f78b8
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-001i-9000000000-da75b3caf532a4f76fd1
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-156.8780072
predicted
DarkChem Lite v0.1.0
[M-H]-153.99022
predicted
DeepCCS 1.0 (2019)
[M+H]+155.4985072
predicted
DarkChem Lite v0.1.0
[M+H]+156.34822
predicted
DeepCCS 1.0 (2019)
[M+Na]+155.2761072
predicted
DarkChem Lite v0.1.0
[M+Na]+162.44136
predicted
DeepCCS 1.0 (2019)

Drug created at July 24, 2007 11:38 / Updated at June 12, 2020 16:51